Law360, San Francisco (May 18, 2011, 7:35 PM EDT) -- Solvay Pharmaceuticals Inc. and two other drugmakers on Tuesday lost bids to disqualify two expert witnesses and two law firms from multidistrict litigation in Georgia over whether the companies' AndroGel patent settlements violated antitrust law.
U.S. District Judge Thomas W. Thrash Jr. said Solvay hadn't produced specific enough evidence or communications showing that plaintiffs' expert Dr. Howard Maibach received confidential information related to underlying patent litigation over the hormone drug while retained by Heim Payne & Chorush LLP and Garwin Gerstein & Fisher LLP.
The judge also ruled that Par Pharmaceutical Cos. Inc. and Paddock Laboratories Inc. didn't sufficiently prove that...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!